Budget Amount *help |
¥513,240,000 (Direct Cost: ¥394,800,000、Indirect Cost: ¥118,440,000)
Fiscal Year 2018: ¥60,840,000 (Direct Cost: ¥46,800,000、Indirect Cost: ¥14,040,000)
Fiscal Year 2017: ¥91,260,000 (Direct Cost: ¥70,200,000、Indirect Cost: ¥21,060,000)
Fiscal Year 2016: ¥91,260,000 (Direct Cost: ¥70,200,000、Indirect Cost: ¥21,060,000)
Fiscal Year 2015: ¥121,680,000 (Direct Cost: ¥93,600,000、Indirect Cost: ¥28,080,000)
Fiscal Year 2014: ¥148,200,000 (Direct Cost: ¥114,000,000、Indirect Cost: ¥34,200,000)
|
Outline of Final Research Achievements |
This research theme is intended to establish the methodology for the elucidation of universal metabolic pathways involved in promoting healthspan as well as for the realization of healthspan. To this end, to date, our laboratory has not only successfully established the science and methodology of calorie restriction appropriate and conducive to lifespan prolongation in higher forms of life and identified universal signaling pathways involved in regulating healthspan, but has also successfully screened preclinical candidate compounds for antidiabetic and healthspan-promoting drugs in its pursuit of the science and methodology for the realization of healthspan in humans, which involves, as a basis, relevant metabolism-regulating pathways.
|